Regeneron Pharmaceuticals Inc [REGN]
$300.58 1.16 (0.39%)
Market Cap 32.08 Billion
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has six marketed products: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Zaltrap in colorectal cancer; Dupixent in atopic dermatitis and asthma; Libtayo in cutaneous squamous cell carcinoma; Arcalyst in CAPS; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer.
EPS 4.23 P/E Ratio 24.20
Previous Earnings Tue, May 7, 2019
Latest Earnings Tue, Aug 6, 2019 (In 19 days)
Pay Date --
|Symbol||Price||Day %||YTD %|
This list of trending stocks may change throughout the trading day.